The Morning Dispatch: What’s Going On at the Justice Department?

Happy Tuesday! Unlike a certain president of the United States, we’re going to send this newsletter on time and not inexplicably make you wait an extra two hours for it.

Quick Hits: Today’s Top Stories

  • Novavax announced yesterday its nanoparticle, protein-based COVID-19 vaccine was 100 percent effective at preventing moderate and severe disease in Phase III trials, and 90 percent effective overall (including 93 percent effective against “predominantly circulating Variants of Concern and Variants of Interest”). If the vaccine receives regulatory approval, the Maryland-based company said it remains on track to manufacture 100 million doses per month by the end of Q3 2021 and 150 million doses per month by the end of Q4 2021.

  • President Joe Biden and Turkish President Recep Erdoğan met in Brussels yesterday during the annual NATO leaders summit, with Biden characterizing their discussion as “positive and productive.” It was the pair’s first face-to-face meeting since the Biden administration formally recognized the Armenian Genocide and the Trump administration sanctioned Turkey for purchasing a Russian missile system.

  • The Senate voted 53-44 yesterday to confirm Judge Ketanji Brown Jackson to the U.S. Court of Appeals for the D.C. Circuit, filling the vacancy created by Merrick Garland’s attorney general nomination. Jackson is widely believed to be on President Biden’s Supreme Court shortlist.

Try 7 Days Free
Become a Dispatch member for unlimited access to our 10 daily and weekly newsletters, Dispatch Live broadcasts, article comments and community events. JOIN ALREADY A PAID SUBSCRIBER? SIGN IN
Comments (0)
Join The Dispatch to participate in the comments.

There are currently no responses to this article.
Be the first to respond.